Orabloc Injection
Product Images NDC 45146-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orabloc (NDC 45146-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pierrel S.p.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Articaine HCl Structural Formula (Orabloc Figure 1)

Articaine HCl Structural Formula (Orabloc Figure 1)
Chemical structure of articaine hydrochloride showing its molecular composition and formula C13H20N2O3S·HCl, corresponding to the active ingredient in Orabloc injection by Pierrel S.p.A.*
FDA Label Image

Epinephrine Bitartrate Structural Formula (Orabloc Figure 2)

Epinephrine Bitartrate Structural Formula (Orabloc Figure 2)
Chemical structure of articaine hydrochloride and epinephrine bitartrate, the active ingredients in Orabloc injection.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartridge Label (Orabloc Figure 3)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartridge Label (Orabloc Figure 3)
Label for Orabloc injection, containing Articaine HCl 4% and Epinephrine 1:100,000. The vial holds 1.8 mL. The label includes the NDC number 45146-110-02, lot number, and expiration date fields, with black printed text on a white background bordered by a pink and gold design. The product is by Pierrel S.p.A.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartron Label (Orabloc Figure 4)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:100,000) Injection Cartron Label (Orabloc Figure 4)
Orabloc 4% articaine hydrochloride and epinephrine 1:100,000 injection carton label for local anesthetic dental use. Contains 50 cartridges of 1.8 mL each, manufactured by Pierrel S.p.A. The label notes sodium metabisulfite content and usage instructions for intramucosal submucosal injection.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartridge Label (Orabloc Figure 5)

Principal Display Panel – Orabloc®  (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartridge Label (Orabloc Figure 5)
Label for Orabloc injection, containing Articaine HCl 4% and Epinephrine 1:200,000. The vial size is 1.8 mL. The label includes an NDC number and spaces for lot number and expiration date but these are not filled in.*
FDA Label Image

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartron Label (Orabloc Figure 6)

Principal Display Panel – Orabloc® (articaine Hydrochloride 4% And Epinephrine 1:200,000) Injection Cartron Label (Orabloc Figure 6)
Packaging label for Orabloc injection containing articaine hydrochloride 4% and epinephrine 1:200,000. The label indicates 50 cartridges, each with 1.8 mL, for intraoral submucosal injection as a local anesthetic for dental use. Manufactured by Pierrel S.p.A. in Italy. The label includes dosage details and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.